TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $324,978 | -38.0% | 21,007 | -37.0% | 0.00% | 0.0% |
| Q2 2023 | $523,850 | -28.5% | 33,345 | -41.0% | 0.00% | -50.0% |
| Q3 2022 | $733,000 | +252.4% | 56,522 | +281.0% | 0.00% | +100.0% |
| Q2 2022 | $208,000 | -78.9% | 14,836 | -74.7% | 0.00% | -80.0% |
| Q2 2021 | $988,000 | +310.0% | 58,677 | +270.3% | 0.01% | +66.7% |
| Q1 2020 | $241,000 | -96.6% | 15,844 | -95.4% | 0.00% | -93.6% |
| Q1 2019 | $7,022,000 | – | 344,714 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |